SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)

NCT02258152 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease Dementia (PDD)

Interventions

DRUG: SYN120
DRUG: Placebo

Sponsor

Biotie Therapies Inc.

Collaborators

[object Object]
[object Object]
[object Object]